291 related articles for article (PubMed ID: 10432377)
1. Molecular mechanisms of diabetic renal hypertrophy.
Wolf G; Ziyadeh FN
Kidney Int; 1999 Aug; 56(2):393-405. PubMed ID: 10432377
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulation in diabetic nephropathy.
Wolf G
Kidney Int Suppl; 2000 Sep; 77():S59-66. PubMed ID: 10997692
[TBL] [Abstract][Full Text] [Related]
3. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
5. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
Baba M; Wada J; Eguchi J; Hashimoto I; Okada T; Yasuhara A; Shikata K; Kanwar YS; Makino H
J Am Soc Nephrol; 2005 Nov; 16(11):3222-34. PubMed ID: 16177004
[TBL] [Abstract][Full Text] [Related]
6. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
Wolf G
Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
[TBL] [Abstract][Full Text] [Related]
8. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up.
Chen S; Jim B; Ziyadeh FN
Semin Nephrol; 2003 Nov; 23(6):532-43. PubMed ID: 14631561
[TBL] [Abstract][Full Text] [Related]
9. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
10. Progression of diabetic nephropathy. Insights from cell culture studies and animal models.
Phillips A; Janssen U; Floege J
Kidney Blood Press Res; 1999; 22(1-2):81-97. PubMed ID: 10352411
[TBL] [Abstract][Full Text] [Related]
11. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
12. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
Nosadini R; Brocco E
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
[TBL] [Abstract][Full Text] [Related]
13. Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia.
Wolf G; Schroeder R; Thaiss F; Ziyadeh FN; Helmchen U; Stahl RA
Kidney Int; 1998 Apr; 53(4):869-79. PubMed ID: 9551393
[TBL] [Abstract][Full Text] [Related]
14. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
[TBL] [Abstract][Full Text] [Related]
15. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1.
Wolf G; Jablonski K; Schroeder R; Reinking R; Shankland SJ; Stahl RA
Kidney Int; 2003 Jul; 64(1):71-81. PubMed ID: 12787397
[TBL] [Abstract][Full Text] [Related]
17. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S; Hong SW; Iglesias-de la Cruz MC; Isono M; Casaretto A; Ziyadeh FN
Ren Fail; 2001; 23(3-4):471-81. PubMed ID: 11499562
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein is a hypertrophy factor for human mesangial cells: Implications for diabetic nephropathy.
Ortega A; Romero M; Izquierdo A; Troyano N; Arce Y; Ardura JA; Arenas MI; Bover J; Esbrit P; Bosch RJ
J Cell Physiol; 2012 May; 227(5):1980-7. PubMed ID: 21732369
[TBL] [Abstract][Full Text] [Related]
19. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
20. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
